Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2026 Earnings Call Transcript November 13, 2025
Aytu BioPharma, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.06.
Operator: Greetings. Welcome to the Aytu BioPharma Fiscal 2026 Q1 Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host, Robert Blum with Investor Relations. You may begin.
Robert Blum: All right. Thank you very much,...
